Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Long-term oral complications of allogeneic haematopoietic SCT

Bone Marrow Transplantation volume 47, pages 265–270 (2012)Cite this article

Abstract

This study assessed the incidence of long-term oral complications in 88 survivors of allogeneic haematopoietic cell transplantation (HCT). Patients examined were between 6 months and 6 years post-HCT and aged from 19 to 65 years. Subjects were investigated for both the subjective and objective features of long-term adverse oral effects of HCT. The most common oral symptoms reported were xerostomia (44%, n=39) and reduction in taste (20%, n=18). Only a minority of patients (15%) reported that oral disease had a significant adverse impact upon their quality of life. The majority of patients (53%) had clinical markers of oral chronic GVHD (cGVHD). The most frequently identified feature was salivary hypofunction, with 34% of subjects demonstrating a reduction in stimulated saliva. Oral mucosal changes consistent with cGVHD affected 21% of subjects. Oral cGVHD commonly occurs after allogeneic HCT, often coexists with cutaneous, hepatic or ocular cGVHD and may lead to debilitating symptoms. Transplant type and pre-existing acute GVHD are the major risk factors for oral cGVHD. The identification of risk factors specific for oral cGVHD may allow clinicians some foresight into identifying patients at high risk of developing oral cGVHD and encourage attention to education, regular oral surveillance and rigorous preventative oral health strategies both pre- and post-transplant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Woo SB, Lee AJ, Schubert MM . Graft-vs-host disease. Crit Rev Oral Biol Med 1997; 8: 201–216.

    Article  CAS  Google Scholar 

  2. Filipovich AH, Weisdorf D, Pavletic SZ . National Institute of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. 1: Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  Google Scholar 

  3. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC . Oral graft-versus-host disease. Oral Dis 2008; 14: 396–412.

    Article  CAS  Google Scholar 

  4. World Health Organisation. World Health Organisation Handbook for Reporting Results of Cancer Treatment. World Health Organisation: Geneva, 1979.

  5. Dworkin SF, LeResche L . Research diagnostic criteria for temporomandibular disorders: Review, Criteria, Examinations and Specifications, Critique. J Craniomandib Disord Fac Oral Pain 1992; 6: 301–355.

    CAS  Google Scholar 

  6. Posselt U . Physiology of Occlusion and Rehabilitation. Blackwell Scientific Publication: Oxford, 1962.

    Google Scholar 

  7. Naylor WP, Douglass CW, Mix E . The nonsurgical treatment of microstomia in scleroderma: a pilot study. Oral Surg Oral Med Oral Path 1984; 57: 508–511.

    Article  CAS  Google Scholar 

  8. Schubert MM, Correa ME . Oral Graft-Versus-Host Disease. Den Clin North Am 2008; 52: 79–109.

    Article  Google Scholar 

  9. Lee S, Cook EF, Soiffer R, Antin JH . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444–452.

    Article  Google Scholar 

  10. Baird K, Pavletic SZ . Chronic graft versus host disease. Curr Opin Hematol 2006; 13: 426–435.

    Article  Google Scholar 

  11. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta analysis. Clinical Oncol 2001; 19: 3685–3691.

    Article  CAS  Google Scholar 

  12. Lee SJ . New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005; 105: 4200–4206.

    Article  CAS  Google Scholar 

  13. Pavletic SZ, Smith LM, Bishop MR . Prognostic factors of chronic graft-versus-host disease after allogenic blood stem-cell transplantation. Am J Hemat 2005; 78: 265–724.

    Article  Google Scholar 

  14. Treister NS, Woo SB, O'Holleran EW, Lehmann LE, Parsons SK, Guinan EC . Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 721–731.

    Article  Google Scholar 

  15. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematological malignancies: an individual patient data meta-analysis of nine randomized trials. Clin Oncol 2005; 23: 5074–5087.

    Article  Google Scholar 

  16. Coracin FL, Pizzigatti Correa ME, Camargo EE . Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods. Bone Marrow Transplant 2006; 37: 955–959.

    Article  CAS  Google Scholar 

  17. Schubert MM, Izutsu KT . Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987; 66: 680–688.

    Article  Google Scholar 

  18. Larsen J, Nordstom G, Ljungman P, Gardulf A . Factors associated with poor general health after stem cell transplantation. Suport Care Cancer 2007; 15: 849–857.

    Article  Google Scholar 

  19. Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu T et al. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 948–956.

    Article  Google Scholar 

  20. Alborghetti MR, Correa ME, Adam RL . Late effects of chronic graft-versus-host disease in minor salivary glands. J Oral Path Med 2005; 34: 486–493.

    Article  CAS  Google Scholar 

  21. da Fonseca MA, Schubert MM, Lloid M . Oral aspects and management of severe graft-vs-host disease in a young patient with beta-thalassemia: case report. Pediatr Dent 1998; 20: 57–61.

    CAS  PubMed  Google Scholar 

  22. Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A . Oral malignancies following HSCT: graft-versus-host disease and other risk factors. Oral Oncol 2005; 41: 865–877.

    Article  Google Scholar 

  23. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904.

    Article  CAS  Google Scholar 

  24. Epstein JB, Raber-Drulacher JE, Wilkins A, Chavarria MG, Myint H . Advances in hematologic stem cell transplant: An update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 301–312.

    Article  Google Scholar 

  25. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski K, Flowers MED et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105: 3802–3811.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank GC Corporation Australia for their donation of Saliva Check Buffer kits used in this study.

Author information

Authors and Affiliations

  1. Department of Oral Medicine, Oral Pathology and Special Needs Dentistry, Westmead Centre for Oral Health, Westmead Hospital, Sydney, New South Wales, Australia

    K M Hull & M Schifter

  2. Blood and Marrow Transplantation Unit (BMTU), Westmead Hospital, Sydney, New South Wales, Australia

    I Kerridge & M Schifter

Authors
  1. K M Hull
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Kerridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Schifter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K M Hull.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hull, K., Kerridge, I. & Schifter, M. Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant 47, 265–270 (2012). https://doi.org/10.1038/bmt.2011.63

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.63

Keywords

This article is cited by

Search

Advanced search

Quick links